Previous Close | 254.85 |
Open | 248.66 |
Bid | 0.00 x 900 |
Ask | 0.00 x 1100 |
Day's Range | 244.42 - 259.86 |
52 Week Range | 164.47 - 279.02 |
Volume | |
Avg. Volume | 1,255,445 |
Market Cap | 79.239B |
Beta (5Y Monthly) | 1.69 |
PE Ratio (TTM) | 19.04 |
EPS (TTM) | 13.38 |
Earnings Date | Apr 20, 2023 - Apr 24, 2023 |
Forward Dividend & Yield | 2.24 (1.04%) |
Ex-Dividend Date | Dec 13, 2022 |
1y Target Est | 240.64 |
HCA Healthcare ( NYSE:HCA ) Full Year 2022 Results Key Financial Results Revenue: US$60.2b (up 2.5% from FY 2021). Net...
At this time, for opening remarks and introductions, I would like to turn the call over to vice president of investor relations, Mr. Frank Morgan. With me this morning is our CEO, Sam Hazen; and CFO, Bill Rutherford.
HCA Healthcare's (HCA) fourth-quarter results suffer a blow from added expenses incurred due to Hurricane Ian. Increased patient admissions partly offset the downside.